Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) - Equities researchers at Zacks Research upped their Q1 2026 earnings per share (EPS) estimates for shares of Phibro Animal Health in a report issued on Wednesday, June 18th. Zacks Research analyst R. Department now anticipates that the company will post earnings of $0.32 per share for the quarter, up from their previous forecast of $0.31. The consensus estimate for Phibro Animal Health's current full-year earnings is $1.95 per share. Zacks Research also issued estimates for Phibro Animal Health's Q2 2026 earnings at $0.59 EPS, Q3 2026 earnings at $0.60 EPS, FY2026 earnings at $2.18 EPS, Q1 2027 earnings at $0.54 EPS and Q2 2027 earnings at $0.58 EPS.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.63 EPS for the quarter, topping the consensus estimate of $0.52 by $0.11. The company had revenue of $347.80 million for the quarter, compared to the consensus estimate of $352.41 million. Phibro Animal Health had a return on equity of 30.51% and a net margin of 2.68%.
Several other brokerages have also weighed in on PAHC. BNP Paribas raised Phibro Animal Health to a "hold" rating in a report on Monday, June 16th. Wall Street Zen raised Phibro Animal Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Morgan Stanley lifted their price objective on Phibro Animal Health from $20.00 to $21.00 and gave the stock an "equal weight" rating in a report on Thursday, May 8th. Finally, BNP Paribas Exane raised Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 price objective on the stock in a report on Monday, June 16th. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $20.80.
Read Our Latest Stock Report on Phibro Animal Health
Phibro Animal Health Stock Performance
Shares of NASDAQ:PAHC traded down $0.08 during trading on Thursday, hitting $23.88. 247,450 shares of the stock were exchanged, compared to its average volume of 207,387. Phibro Animal Health has a 1-year low of $16.16 and a 1-year high of $26.55. The company has a market capitalization of $967.95 million, a price-to-earnings ratio of 30.62, a price-to-earnings-growth ratio of 0.45 and a beta of 0.74. The company's fifty day simple moving average is $21.85 and its 200-day simple moving average is $21.91. The company has a debt-to-equity ratio of 2.67, a quick ratio of 1.23 and a current ratio of 2.91.
Phibro Animal Health Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Wednesday, June 4th will be paid a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 2.01%. The ex-dividend date is Wednesday, June 4th. Phibro Animal Health's dividend payout ratio is 61.54%.
Institutional Trading of Phibro Animal Health
Institutional investors have recently bought and sold shares of the stock. Man Group plc acquired a new stake in Phibro Animal Health in the 4th quarter valued at $501,000. GAMMA Investing LLC boosted its stake in Phibro Animal Health by 2,011.4% in the 1st quarter. GAMMA Investing LLC now owns 36,718 shares of the company's stock valued at $784,000 after buying an additional 34,979 shares in the last quarter. Lazard Asset Management LLC boosted its stake in Phibro Animal Health by 2,739.7% in the 4th quarter. Lazard Asset Management LLC now owns 1,647 shares of the company's stock valued at $34,000 after buying an additional 1,589 shares in the last quarter. Nuveen Asset Management LLC boosted its stake in Phibro Animal Health by 21.4% in the 4th quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company's stock valued at $12,348,000 after buying an additional 103,618 shares in the last quarter. Finally, Alliancebernstein L.P. boosted its stake in Phibro Animal Health by 357.1% in the fourth quarter. Alliancebernstein L.P. now owns 130,000 shares of the company's stock worth $2,730,000 after purchasing an additional 101,560 shares in the last quarter. Institutional investors and hedge funds own 99.34% of the company's stock.
About Phibro Animal Health
(
Get Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Read More
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
